Funding for this research was provided by:
National Natural Science Foundation of China (81772620)
National Key R&D Program of China (2018ZX09201015)
Tianjin Science and Technology Major Project of Chronic Diseases Prevention and Control (17ZXMFSY00130)
Received: 23 April 2021
Accepted: 10 September 2021
First Online: 2 October 2021
: All of the patients provided written informed consent, and this study was approved by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (Ek2017002).
: Not applicable.
: The authors declare that they have no competing interests.